Shares of Aastrom Biosciences (NASDAQ:ASTM) traded at a new 52-week low today of $0.61. So far today approximately 588,000 shares have been exchanged, as compared to an average 30-day volume of 490,000 shares.
There is potential upside of 490.0% for shares of Aastrom Biosciences based on a current price of $0.63 and an average consensus analyst price target of $3.72. The stock should find initial resistance at its 50-day moving average (MA) of $1.01 and further resistance at its 200-day MA of $1.41.
Aastrom Biosciences, Inc. develops autologous stem/progenitor cell products for the repair/regeneration of tissues based on Tissue Repair Cell (TRC) adult stem cell technology. The Company's products contain bone marrow stem and progenitor cells that are produced from cells originating from the patient.
Aastrom Biosciences share prices have moved between a 52-week high of $2.61 and the current low of $0.61 and are currently at $0.63 per share. Over the past week, the 200-day moving average (MA) has gone down 2.5% while the 50-day MA has declined 5.9%.